Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hybridopa
- Development stage
- Unknown
- Lead developer
- Remepy
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Hybridopa is a novel hybrid therapeutic developed by Remepy that combines a levodopa-based small molecule with a digital therapeutic protocol (Software as a Medical Device). It is specifically designed for the treatment of Parkinson's Disease, targeting both motor symptoms like rigidity and non-motor symptoms such as cognitive decline. The pharmacological component, levodopa, acts as a dopamine precursor that is converted into dopamine in the central nervous system to restore neurotransmitter levels. The integrated digital therapeutic component is designed to optimize treatment outcomes and manage symptoms through autonomic regulation or behavioral interventions. The program has completed Phase 2 clinical trials and is scheduled to enter Phase 3 in late 2026.
- Brand names
- Hybridopa
- Other names
- Hybridopa™
02
Targets
DRD (Dopamine receptors)
Beyond the preview
Go deeper on Hybridopa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hybridopa.